The Usefulness of STEAP Proteins in Prostate Cancer Clinical Practice
Article Sidebar
Main Article Content
ABSTRACT
Prostate cancer is a multifactorial disease and the second most common cancer diagnosed in men worldwide. The six transmembrane epithelial antigen of prostate (STEAP) proteins seem to be involved in prostate tumorigenesis. The STEAP proteins are differentially expressed in prostate cancer cells, and survival analysis reveal that prostate cancer patients with high levels of STEAP1 have poor survival outcomes. In contrast, high expression of STEAP4 offers a better prognosis. This chapter provides an overview of the role of STEAP proteins in prostate cancer. The structure, biological functions, and the potential prognostic significance of each of the four members of the STEAP family in prostate cancer are discussed.
Downloads
Metrics
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of individual chapters belongs to the respective authors. The authors grant unrestricted publishing and distribution rights to the publisher. The electronic versions of the chapters are published under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Users are allowed to share and adapt the chapters for any non-commercial purposes as long as the authors and the publisher are explicitly identified and properly acknowledged as the original source. The books in their entirety are subject to copyright by the publisher. The reproduction, modification, republication and display of the books in their entirety, in any form, by anyone, for commercial purposes are strictly prohibited without the written consent of the publisher.